Linked Life Data

12776015

Source:http://linkedlifedata.com/resource/pubmed/id/12776015

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-5-30
pubmed:abstractText
Among postmenopausal women, 38% use hormone replacement therapy (HRT)- the leading brand of conjugated equine estrogen is the second most prescribed drug in the United States. Although adverse effects of this therapy have been recognized, it was traditionally reasoned that HRT could be broadly recommended to postmenopausal women because coronary heart disease was their most significant health risk. Evolving vascular biologic understanding, however, suggests that HRT, in direct opposition to the existing observational study data, does not reduce coronary heart disease risk. During the summer of 2002, three important studies on HRT dramatically changed our view of this widespread treatment. These trials provide clear, new, guidelines for patients and physicians contemplating HRT therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1530-6550
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68-71
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
The changing view of hormone replacement therapy.
pubmed:affiliation
Division of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USA.
pubmed:publicationType
Journal Article, Review